Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

N4 Pharma Plc (N4P) Share Price

Price 0.625p on 14-11-2025 at 19:10:07
Change 0.00p 0%
Buy 0.65p
Sell 0.60p
Last Trade: Sell 1,000.00 at 0.60p
Day's Volume: 1,106,400
Last Close: 0.625p
Open: 0.625p
ISIN: GB00BYW8QM32
Day's Range 0.625p - 0.625p
52wk Range: 0.35p - 0.80p
Market Capitalisation: £5.20m
VWAP: 0.58036p
Shares in Issue: 832.28m

N4 Pharma Plc (N4P) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,000 0.60p SI Trade
13:15:27 - 14-Nov-25
Buy* 400 0.65p SI Trade
13:15:27 - 14-Nov-25
Unknown* 1,100,000 0.58p Negotiated Trade
11:14:16 - 14-Nov-25
Buy* 5,000 0.65p SI Trade
10:46:43 - 14-Nov-25
Buy* 20,000 0.629p Ordinary
12:47:27 - 13-Nov-25
Buy* 56,028 0.63p Ordinary
10:21:47 - 13-Nov-25
Buy* 153 0.65p Ordinary
10:15:02 - 13-Nov-25
Sell* 3,400 0.60p SI Trade
08:30:52 - 13-Nov-25
Sell* 5,555 0.60p SI Trade
08:30:52 - 13-Nov-25
Sell* 12,941 0.6188p Ordinary
08:11:41 - 13-Nov-25
See more N4 Pharma Plc trades

N4 Pharma Plc (N4P) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Nov 2025 (Fri) 0.625 0.625 0.625 0.625 1,106,400
13th Nov 2025 (Thu) 0.625 0.625 0.625 0.625 103,327
12th Nov 2025 (Wed) 0.625 0.625 0.625 0.625 2,125,934
11th Nov 2025 (Tue) 0.625 0.625 0.625 0.625 554,847
10th Nov 2025 (Mon) 0.625 0.625 0.59 0.625 1,826,092
7th Nov 2025 (Fri) 0.625 0.625 0.625 0.625 641,863
6th Nov 2025 (Thu) 0.60 0.625 0.55 0.625 3,410,706
5th Nov 2025 (Wed) 0.60 0.60 0.55 0.60 26,833
4th Nov 2025 (Tue) 0.60 0.60 0.60 0.60 843,537
3rd Nov 2025 (Mon) 0.60 0.60 0.60 0.60 222,922
31st Oct 2025 (Fri) 0.60 0.545 0.545 0.60 814,113
30th Oct 2025 (Thu) 0.60 0.60 0.60 0.60 130,059
29th Oct 2025 (Wed) 0.60 0.55 0.55 0.60 235,951
28th Oct 2025 (Tue) 0.60 0.60 0.60 0.60 500,000
27th Oct 2025 (Mon) 0.60 0.65 0.65 0.65 1,835,113
24th Oct 2025 (Fri) 0.60 0.545 0.545 0.60 128,382
23rd Oct 2025 (Thu) 0.60 0.60 0.60 0.60 528,361
22nd Oct 2025 (Wed) 0.60 0.60 0.60 0.60 127,880
21st Oct 2025 (Tue) 0.60 0.60 0.60 0.60 1,473,843
20th Oct 2025 (Mon) 0.60 0.60 0.60 0.60 87,856
17th Oct 2025 (Fri) 0.60 0.60 0.60 0.60 1,674,157
16th Oct 2025 (Thu) 0.60 0.60 0.60 0.60 367,775
See more N4 Pharma Plc price history

N4 Pharma Plc (N4P) Regulatory News

Date Source Headline
25th Sep 2025 7:00 am RNS Interim Results
23rd Sep 2025 7:00 am RNS Partnership with University of Strathclyde’s CMAC
22nd Sep 2025 7:00 am RNS N4 Pharma’s Nuvec® Targets Lung Cancer Cells
19th Sep 2025 7:00 am RNS Notice of Results, Analyst & Investor Presentation
11th Sep 2025 7:00 am RNS-R Investor Event and Presentation
30th Jul 2025 1:55 pm RNS-R Article on Nuvec®’s Potential in RNA Therapeutics
14th Jul 2025 7:00 am RNS-R Investor Webinar
8th Jul 2025 7:00 am RNS Directorate Change
30th Jun 2025 2:15 pm RNS Result of AGM
30th Jun 2025 7:00 am RNS AGM Statement
See more N4 Pharma Plc regulatory news

N4 Pharma Plc (N4P) Share News

EARNINGS AND TRADING: Comptoir loss narrows; Journeo profit down

25th Sep 2025 13:43

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: N4 Pharma teams up with University of Strathclyde facility

23rd Sep 2025 18:29

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of nanoparticle technology - Announces partnership with Glasgow-based University of Strathclyde's CMAC National Facility, aimed at accelerating development and broadening therapeutic applications. The collaboration combines N4 Pharma's Nuvec delivery platform with CMAc's expertise. Read More

AIM WINNERS & LOSERS: WH Ireland agrees disposal, proposes wind-down

22nd Sep 2025 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

N4 Pharma surges as Nuvec targets RNA delivery to lung cancer cells

22nd Sep 2025 10:24

(Alliance News) - N4 Pharma PLC on Monday said its Nuvec gene delivery system has successfully demonstrated targeted delivery of RNA to lung cancer cells in collaboration with US research institute SRI. Read More

LONDON MARKET OPEN: London stocks mixed as mining stocks rise

22nd Sep 2025 09:11

(Alliance News) - London stocks were mixed at Monday's market open, with miners dominating the top spots on the FTSE 100 index while airlines were hurt after the weekend's alleged cyber attack. Read More

See more N4 Pharma Plc news
FTSE 100 Latest
Value9,698.37
Change-109.31

Login to your account

Forgot Password?

Not Registered